Pharsight

Sun Pharm Inds Inc patents expiration

1. Absorica patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8952064 SUN PHARM INDS INC Pharmaceutical semi-solid composition of isotretinoin
Sep, 2021

(2 years ago)

US9089534 SUN PHARM INDS INC Pharmaceutical semi-solid composition of isotretinoin
Sep, 2021

(2 years ago)

US8367102 SUN PHARM INDS INC Pharmaceutical semi-solid composition of isotretinoin
Sep, 2021

(2 years ago)

US9078925 SUN PHARM INDS INC Pharmaceutical semi-solid composition of isotretinoin
Sep, 2021

(2 years ago)

US7435427 SUN PHARM INDS INC Pharmaceutical semi-solid composition of isotretinoin
Sep, 2021

(2 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) May 25, 2015

Drugs and Companies using ISOTRETINOIN ingredient

Market Authorisation Date: 25 May, 2012

Treatment: Treatment of a skin disorder

Dosage: CAPSULE;ORAL

How can I launch a generic of ABSORICA before it's drug patent expiration?
More Information on Dosage

ABSORICA family patents

Family Patents

2. Ortikos patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9707182 SUN PHARM INDS INC Oral pharmaceutical dosage forms of budesonide
Sep, 2036

(12 years from now)

US10172802 SUN PHARM INDS INC Oral pharmaceutical dosage forms of budesonide
Sep, 2036

(12 years from now)

Drugs and Companies using BUDESONIDE ingredient

Market Authorisation Date: 13 June, 2019

Treatment: Treatment of mild to moderate active crohn's disease involving the ileum and/or the ascending colon

Dosage: CAPSULE, DELAYED RELEASE;ORAL

More Information on Dosage

ORTIKOS family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Sezaby patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11857683 SUN PHARM INDS INC Stabilization of phenobarbital sodium for injection
Apr, 2042

(17 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-414) Nov 17, 2029

Drugs and Companies using PHENOBARBITAL SODIUM ingredient

Market Authorisation Date: 17 November, 2022

Treatment: Method of treating neonatal seizures

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

SEZABY family patents

Family Patents